APA (7th ed.) Citation

Saba, C. F., Vickery, K. R., Clifford, C. A., Burgess, K. E., Phillips, B., Vail, D. M., . . . Thamm, D. H. (2018). Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses. Veterinary & Comparative Oncology, 16(1), E76. https://doi.org/10.1111/vco.12337

Chicago Style (17th ed.) Citation

Saba, C. F., et al. "Rabacfosadine for Relapsed Canine B-cell Lymphoma: Efficacy and Adverse Event Profiles of 2 Different Doses." Veterinary & Comparative Oncology 16, no. 1 (2018): E76. https://doi.org/10.1111/vco.12337.

MLA (9th ed.) Citation

Saba, C. F., et al. "Rabacfosadine for Relapsed Canine B-cell Lymphoma: Efficacy and Adverse Event Profiles of 2 Different Doses." Veterinary & Comparative Oncology, vol. 16, no. 1, 2018, p. E76, https://doi.org/10.1111/vco.12337.